Effect of preexisting immunity to Salmonella on the immune response to recombinant Salmonella enterica serovar Typhimurium expressing a Porphyromonas gingivalis hemagglutinin

Infection and Immunity

Volumn 68, Issue 6, 2000, Pages 3116-3120

  Kohler, James J ^a   Pathangey, Latha B ^a   Gillespie, Sheila R ^a   Brown, Thomas A ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; RECOMBINANT VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PEYER PATCH; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; SALMONELLA ENTERICA; STOMACH INTUBATION;

ADHESINS, BACTERIAL; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; BACTEROIDACEAE INFECTIONS; FEMALE; HEMAGGLUTININS; IMMUNIZATION, SECONDARY; LECTINS; MICE; MICE, INBRED BALB C; PEYER'S PATCHES; PORPHYROMONAS GINGIVALIS; SALIVA; SALMONELLA; SALMONELLA TYPHIMURIUM; SPLEEN; VACCINATION; VACCINES, SYNTHETIC; VAGINA;

EID: 0034115850     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.6.3116-3120.2000     Document Type: Article

References (22)

1. Attridge, S. R., R. Davies, and J. T. LaBrooy. 1997. Oral delivery of foreign antigens by attenuated Salmonella: consequences of prior exposure to the vector strain. Vaccine 15:155-162.
2. Bao, J. X., and J. D. Clements. 1991. Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers. Infect. Immun. 59:3841-3845.
3. Bernfeld, P. 1955. Amylases α and β. Methods Enzymol. 1:149-158.
4. Cárdenas, L., and J. D. Clements. 1992. Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens. Clin. Microbiol. Rev. 5:328-342.
5. Chatfield, S. N., K. Strahan, D. Pickard, I. G. Charles, C. E. Hormaeche, and G. Dougan. 1992. Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model. Microb. Pathog. 12:145-151.
6. Curtiss, R., III, and S. M. Kelly. 1987. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect. Immun. 55:3035-3043.
7. Dunstan, S. J., C. P. Simmons, and R. A. Strugnell. 1998. Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen. Infect. Immun. 66:732-740.
8. Dusek, D. M., A. Progulske-Fox, and T. A. Brown. 1994. Systemic and mucosal immune responses in mice orally immunized with an avirulent Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin. Infect. Immun. 62:1652-1657.
9. Dusek, D. M., A. Progulske-Fox, J. Whitlock, and T. A. Brown. 1993. Isolation and characterization of a cloned Porphyromonas gingivalis hemagglutinin from an avirulent strain of Salmonella typhimurium. Infect. Immun. 61:940-946.
10. Finch, C. E. 1990. Longevity, senescence, and the genome. University of Chicago Press, Chicago, Ill.
11. Fridman, W. H. 1993. Regulation of B-cell activation and antigen presentation by Fc receptors. Curr. Opin. Immunol. 5:355-360.
12. Galán, J. E., K. Nakayama, and R. Curtiss III. 1990. Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene 94:29-35.
13. Germanier, R., and E. Fürer. 1975. Isolation and characterisation of galE mutant Ty21A of Salmonella typhi: a candidate strain for live, oral typhoid vaccine. J. Infect. Dis. 131:553-558.
14. Hantman, M. J., E. L. Hohmann, C. G. Murphy, D. M. Knipe, and S. I. Miller. 1999. Antigen delivery systems: development of recombinant live vaccines using viral or bacterial vectors, p. 779-791. In P. L. Ogra, J. Mestecky, M. E. Lamm, W. Strober, J. Bienenstock, and J. R. McGhee (ed.), Mucosal immunology. Academic Press, Inc., San Diego, Calif.
15. Hoiseth, S. K., and B. A. D. Stocker. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238-239.
16. Kohler, J. J., L. B. Pathangey, and T. A. Brown. 1998. Oral immunization with recombinant Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin: effect of boosting on mucosal, systemic and immunoglobulin G subclass response. Oral Microbiol. Immunol. 13:81-88.
17. McFarland, W. C., and B. A. D. Stocker. 1987. Effect of different purine auxotrophic mutations on mouse-virulence of a Vi-positive strain of Salmonella dublin and of two strains of Salmonella typhimurium. Microb. Pathog. 3:129-141.
18. O'Callaghan, D., D. Maskell, F. Y. Liew, C. S. Easmon, and G. Dougan. 1988. Characterization of aromatic-and purine-dependent Salmonella typhimurium: attenuation, persistence, and ability to induce protective immunity in BALB/c mice. Infect. Immun. 56:419-423.
19. Roberts, M., A. Bacon, J. Li, and S. Chatfield. 1999. Prior immunity to homologous and heterologous Salmonella serotypes suppresses local and systemic anti-fragment C antibody responses and protection from tetanus toxin in mice immunized with Salmonella strains expressing fragment C. Infect. Immun. 67:3810-3815.
20. Schödel, F., and R. Curtiss III. 1995. Salmonellae as oral vaccine carriers. Dev. Biol. Stand. 84:245-253.
21. Stocker, B. A. D. 1988. Auxotrophic Salmonella typhi as live vaccine. Vaccine 6:141-145.
22. Whittle, B. L., and N. K. Verma. 1997. The immune response to a B-cell epitope delivered by Salmonella is enhanced by prior immunological experience. Vaccine 15:1737-1740.